Repurposing PDE5 inhibitor tadalafil and sildenafil as anticancer agent against hepatocellular carcinoma via targeting key events of glucose metabolism and multidrug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repurposing PDE5 inhibitor tadalafil and sildenafil as anticancer agent against hepatocellular carcinoma via targeting key events of glucose metabolism and multidrug resistance

Published:2022-05-24 Issue:8 Volume:36 Page:
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem & Molecular Tox

Author:

Chhonker Saurabh Kumar¹,Rawat Divya¹,Koiri Raj Kumar¹^ORCID

Affiliation:

1. Biochemistry Laboratory, Department of Zoology, School of Biological Sciences Dr. Harisingh Gour Vishwavidyalaya (A Central University) Sagar Madhya Pradesh India

Funder

University Grants Commission

Science and Engineering Research Board

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.23100

Reference52 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Hepatocellular carcinoma

3. Role of Vascular Endothelial Growth Factor and Transforming Growth Factor-beta in Hepatocellular Carcinoma

4. Gut microbiota, fatty liver disease, and hepatocellular carcinoma

5. Modulation of antioxidant enzymes, SIRT1 and NF‐κB by resveratrol and nicotinamide in alcohol‐aflatoxin B1‐induced hepatocellular carcinoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in bmpr2‐silenced human lung microvascular endothelial cells;Pulmonary Circulation;2023-10

2. Cancer Metabolism as a Therapeutic Target and Review of Interventions;Nutrients;2023-10-01

3. Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives;Pharmaceuticals;2023-09-06

4. Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma;Cancers;2023-07-15

5. Tadalafil Rescues the p.M325T Mutant of Best1 Chloride Channel;Molecules;2023-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3